NVCR FY 2021 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

FY 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$535M+8.2% YoY

Gross Profit

$420M78.5% margin

Operating Income

-$44M-8.3% margin

Net Income

-$58M-10.9% margin

EPS (Diluted)

$-0.56

Cash Flow

Operating Cash Flow

$83M

Free Cash Flow

$59M

Stock-Based Comp.

$95M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$729M

Stockholders' Equity

$410M

Cash & Equivalents

$210M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$535M	$494M	+8.2%
Gross Profit	$420M	$388M	+8.3%
Operating Income	-$44M	$30M	-245.8%
Net Income	-$58M	$20M	-394.6%